Molecular epidemiology of Mycobacterium tuberculosis complex in Brussels, 2010-2013 by Vluggen, C. et al.
RESEARCH ARTICLE
Molecular epidemiology of Mycobacterium
tuberculosis complex in Brussels, 2010–2013
Christelle Vluggen1, Karine Soetaert1, Guido Groenen2, Maryse Wanlin2,
Martine Spitaels2, Wouter Arrazola de Oñate2, Maryse Fauville-Dufaux1,
Claude Saegerman3, Vanessa Mathys1*
1 Bacterial Diseases Service, Operational Direction Communicable and Infectious Diseases, Scientific
Institute of Public Health (WIV-ISP), Brussels, Belgium, 2 Belgian Lung and Tuberculosis Association,
Brussels, Belgium, 3 Research Unit of Epidemiology and Risk Analysis applied to Veterinary Sciences
(UREAR-ULg), Fundamental and Applied Research for Animal and Health (FARAH) Centre, Liège, Belgium
* vmathys@wiv-isp.be
Abstract
The tuberculosis (TB) incidence rate in Brussels-Capital Region is 3-fold higher than in Bel-
gium as a whole. Eight years after the realization of initial prospective population-based
molecular epidemiology investigations in this Region, a similar study over the period 2010–
2013 was conducted. TB strains isolated from 945 patients were submitted to genotyping by
standardized 24-locus-MIRU-VNTR typing and spoligotyping. The phylogenetic analysis
showed that the LAM (16.7%) and Haarlem (15.7%) branches are the two most prevalent
TB lineages circulating in Brussels. Analysis of the MDR subgroup showed an association
with Beijing strains (39.9%) and patients native of Eastern Europe (40.7%). Genotyping
detected 113 clusters involving 321 patients, giving a recent transmission index of 22.9%.
Molecular-guided epidemiological investigations and routine surveillance activities revealed
family transmission or social contact for patients distributed over 34 clusters. Most of the
patients were foreign-born (75.7%). However, cluster analysis revealed only limited trans-
national transmission. Comparison with the previous study shows a stable epidemiological
situation except for the mean age difference between Belgian-born and foreign-born
patients which has disappeared. This study confirms that molecular epidemiology has
become an important determinant for TB control programs. However, sufficient financial
means need to be available to perform all required epidemiological investigations.
Introduction
Tuberculosis (TB) remains a major public health concern, even in developed countries.
According to the World Health Organisation (WHO), an estimated 10.4 million people devel-
oped TB in 2015 and 1.4 million died from the disease [1]. In Belgium, the incidence in 2015
was 8.8 cases per 100,000 inhabitants, explaining its status of low TB incidence country. How-
ever, TB incidence rate in Brussels-Capital Region (25.9/100,000) is almost 3-fold higher than
for the whole country while more than two thirds of the patients are foreign-born [2]. Belgium
is a migration crossroad. During the study period, immigration from Eastern and Central
Europe was increasing [3].
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Rapid detection, adequate therapy, and contact tracing are key elements to stop further
transmission and control the disease. Genotyping of Mycobacterium tuberculosis complex (M.
tuberculosis), the causative agent of TB, can help to control the spread of the disease. Indeed, it
allows the detection of unsuspected transmission, the discovery of laboratory contamination
and the differentiation between reactivation and relapse [4]. Moreover, genotyping may also
be useful to guide contact investigations, identify risk populations and evaluate the effective-
ness of TB control programs [4,5].
Since 2003, the Belgian TB National Reference Laboratory performs TB strain typing by
using the two main available techniques, 24-locus-MIRU-VNTR and spoligotyping; both are
polymerase chain reaction (PCR)-based methods. Spoligotyping detects the presence or
absence of spacer sequences located between repetitive elements by PCR and reverse dot-blot
analysis [6]. This technique is easy and cheap but, used alone, presents a lack of discriminatory
power [7]. MIRU-VNTR is based on the analysis of 24 loci containing variable numbers of tan-
dem repeats (VNTRs) of genetic elements called mycobacterial interspersed repetitive units
(MIRUs) [8–10]. Genotyping using a combination of spoligotyping and MIRU-VNTR has
been shown to be generally as effective to study transmission of TB in Western Europe popula-
tions as IS6110 RFLP, which was considered as the previous gold standard for molecular epide-
miogy of TB [11–13].
From 2002 to 2005, an initial prospective population-based molecular epidemiology study
in the Brussels-Capital Region has been realised [11,14]. Genetic lineages of the M. tuberculosis
strains were determined based on the spoligotypes and patient clustering was detected through
the analysis of 24-locus-MIRU-VNTR and spoligotyping patterns. Eight years later, a similar
study over 48 months was conducted in order to evaluate the evolution of the epidemiological
situation, the M. tuberculosis transmission rate in Brussels, the effectiveness of recently imple-
mented measures for improving surveillance as well as treatment access and follow-up of
patients.
Materials and methods
Study subjects and design
From 1 January 2010 to 31 December 2013, the five hospitals of the Brussels-Capital Region
that perform mycobacterial cultures and the Scientific Institute of Public Health (WIV-ISP),
Brussels, Belgium, sent all M. tuberculosis cultures to the Tuberculosis and Mycobacteria Refer-
ence Center at the WIV-ISP, where one isolate from each patient was genotyped. Species iden-
tification was realized by the participating laboratories/hospitals using different techniques
including PCR amplification of the IS6110 element, MGITTM TBc Identification test (Becton
Dickinson, Sparks, MD), SD Bioline TB Ag MPT64 Rapid test (Standard Diagnostics, Yongin,
Korea) and Xpert1 MTB/RIF assay (Cepheid, Sunnyvale, CA, USA). Drug susceptibility test-
ing was conducted by the participating laboratories using the MGITTM method (BactecTM,
BD).
Molecular typing method and analysis of patterns
The M. tuberculosis strains were submitted to genotyping by two different methods performed
as previously described: spoligotyping [6] and standardized 24-locus-MIRU-VNTR typing
using a four-capillary-based ABI3130-Avant genetic analyser [15,16]. Genetic lineages of the
strains were determined by comparison of the obtained spoligotypes with those recorded at
the www.miru-vntrplus.org [17,18]. Spoligotyping and MIRU-VNTR patterns were analyzed
using the Bionumerics package, version 7.1 (Applied Maths, St-Martin-Latem, Belgium). Den-
drograms were generated using the Pearson correlation and the unweighted-pair group
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method with arithmetic average linkages. A strain cluster was defined as two or more patients
infected by isolates having identical spoligotypes and 24-locus-MIRU-VNTR patterns. Assum-
ing that one patient from each strain cluster corresponded to the index case at the origin of
infection, the strain-clustering rate (or recent transmission index, RTI) was calculated with the
following equation: RTIn − 1 = (nc − c)/n, where nc is the total number of strain-clustered cases,
c is the number of strain clusters, and n is the total number of cases in the sample [11,19].
Patients’ information and epidemiological investigation
Some clinical and laboratory information (smear microscopy, site of infection, drug susceptibil-
ity testing and ambulatory/hospitalized patient status) were obtained through a questionnaire
completed by the participating hospitals. The other clinical and demographic information were
collected from the Belgian Tuberculosis Register. Anonymous data were obtained on sex, date
and country of birth, place of residence, diabetes status, HIV status, cancer, alcoholism, kidney
disease, recent contact (<2 years) with a TB patient, previous TB diagnosis, and socioeconomic
status. All data accessed in the context of the present study had not been collected for research
purposes but as part of the routine data collection for epidemiological surveillance, as stated in
the Public Register dated 25/04/1997 in accordance with article 18 of the law of 08/12/1992 of
the Belgian Government regarding the protection of the privacy of the individual when dealing
with personal data. The aforementioned registration in accordance with the Belgian Privacy
Commission stipulates in its §9 that no written informed consent from the patients is required
for the collection and analysis of epidemiological data and treatment success collected for a pub-
lic health purpose. The analysis of the data was realized after anonymization. The study was
approved by the ethic committee of the Erasme University Hospital, one of the participating
institutions (reference P2010/027).
Statistical analysis
The frequencies and proportions observed in the clustered and non-clustered TB cases and in
the multidrug resistant (MDR) and non-MDR TB cases were compared using the Chi2 test.
The relationship between TB status (cluster versus non-cluster) and different exploratory vari-
ables (Table 1) was assessed using the odds ratio (OR) that were determined by logistic regres-
sion. When complete separation (zero cells) occurred, the Firth logit regression was used
allowing inference of ORs and 95% confidence interval [20]. Differences in age between clus-
tered and non-clustered TB cases were assessed using a two-sample Wilcoxon rank-sum
(Mann-Whitney) test. For all tests, a P values< 0.05 was considered significant.
Results
Clinical isolates
From 1 January 2010 to 31 December 2013, the Belgian Lung and Tuberculosis Association
(BELTA) registered 1342 TB cases in the Brussels-Capital Region, 1068 (79.6%) of them being
culture-positive. The isolates from 954 (89.3%) of the culture-positive patients were sent to the
National Reference Laboratory where one strain per patient was selected for inclusion in the
study. Of these, nine cases were excluded because of laboratory cross-contamination (n = 7)
and labeling/patient identification error (n = 2) as confirmed by genotyping and laboratory/
clinical investigation (samples collected or processed the same day and/or absence of clinical
TB symptoms). A total of 945 TB isolates were included in the study. Additional efforts to
retrieve the 114 missing cultures were made unsuccessfully. As previously described, young
patients (less than 15 years; n = 67) and patients with extrapulmonary TB (n = 139), known to
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Table 1. Characteristics of Mycobacterium tuberculosis complex strains isolated from tuberculosis patients living in Brussels and two sub-
groups; no-clustered and clustered strains, 2010–2013.
Category All strains included in the
study (n = 945)
Non-clustered strains
(n = 624)






















<15 years 38/945 4.02 14/624 2.24 24/321 7.48 3.53 (1.76–
7.09)
0.001
15–29 years 276/945 29.21 177/624 28.37 99/321 30.84 1.15 (0.83–
1.61)
0.40
30–44 years 346/945 36.61 233/624 37.34 113/321 35.20 Reference -
45–59 years 162/945 17.14 111/624 17.79 51/321 15.89 0.95 (0.63–
1.41)
0.79




Pulmonary 697/920 75.76 437/606 72.11 260/314 82.80 1.86 (1.32–
2.62)
<0.001
Extrapulmonary 223/920 24.24 169/606 27.89 54/314 17.2 Reference -
Smear microscopy positive 320/627 51.04 193/391 49.36 127/236 53.81 1.20(0.85;1.67) 0.28
Native country
Belgium 207/850 24.35 107/557 19.21 100/293 33.90 2.18 (1.58–
3.00)
<0.001
Other countries 643/850 75.65 450/557 80.79 193/293 65.87 Reference -
North Africa 180/850 21.18
Sub-Saharan Africa 192/850 22.59
Asia–Oceania 114/850 13.41
America 18/850 2.11
East Europe 92/850 10.82
Western and central Europe 47/850 5.53
Genetic sublineage
Beijing 37/910 4.07 25/589 4.24 12/321 3.74 0.59 (0.28–
1.24)
0.17
ast Africa Indian 19/910 2.09 19/589 3.23 0/321 0.00 0.03 (0.002–
0.52)
0.02
Delhi/CAS 51/910 5.60 35/589 5.94 16/321 4.98 0.51 (0.26–
1.01)
0.05
LAM 152/910 16.70 83/589 14.09 69/321 21.50 Reference -
Cameroon 19/910 2.09 12/589 2.04 7/321 2.18 0.72 (0.27–
1.88)
0.50
TUR 2/910 0.22 2/589 0.34 0/321 0.00 0.24 (0.01–
5.09)
0.36
Haarlem 143/910 15.71 85/589 14.43 58/321 18.07 0.82 (0.52–
1.30)
0.40
NEW-1 1/910 0.11 1/589 0.17 0/321 0.00 0.40 (0.02–
9.98)
0.58
S 30/910 3.30 15/589 2.55 15/321 4.67 1.20 (0.55–
2.60)
0.64
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Table 1. (Continued)
Category All strains included in the
study (n = 945)
Non-clustered strains
(n = 624)

















URAL 56/910 6.15 23/589 3.91 33/321 10.28 1.71 (0.93–
3.17)
0.09
Ghana 92/910 10.11 55/589 9.34 37/321 11.53 0.81 (0.48–
1.37)
0.43
Uganda I 18/910 1.98 14/589 2.38 4/321 1.25 0.37 (0.12–
1.13)
0.08
Uganda II 5/910 0.55 3/589 0.51 2/321 0.62 0.86 (0.16–
4.49)
0.86
T or undefined 236/910 25.93 174/589 29.54 62/321 19.31 0.85 (0.51–
1.41)
0.52
M. africanum 16/910 1.76 14/589 21.39 2/321 0.62 0.21 (0.05–
0.82)
0.03




Isoniazid mono-resistance 45/922 4.88 24/606 3.96 21/316 6.65 1.72 (0.94–
3.15)
0.08
Rifampicin mono-resistance 4/922 0.43 2/606 0.33 2/316 0.63 1.97 (0.28–
14.05)
0.50
Multidrug resistance 30/922 3.25 21/606 3.47 9/316 2.85 0.84 (0.38–
1.87)
0.67
Pan-susceptible 843/922 91.43 559/606 92.24 284/316 89.87 Reference -
Previous history of TB 51/783 6.51 36/517 6.96 15/266 58/286 5.64 0,81(0,41;1,54) 0.48
Asylum-seekers or
undocumented immigrants
214/861 24.85 156/575 27.13 20.28 0,68(0,48;0,97) 0.03
Prisoners 28/892 3.14 17/593 2.87 11/299 3.68 1.29 (0.60–
2.80)
0.51





36/836 4.31 26/556 4.68 10/280 3.57 0.75 (0.36–
1.59)
0.46
Underprivileged 333/804 41.42 214/532 40.23 119/272 43.75 1.16 (0.86–
1.55)
0.34
Alcohol abuser 49/821 5.97 24/548 4.38 25/273 9.16 2.20 (1.29–
3.93)
0.008
Homeless 35/876 3.99 25/586
38/265
4.27 10/290 3.45 0.80 (0.38–
1.69)
0.56
Contact < 2 years 95/408 23.28 14.34 57/143 39.86 3.96 (2.45–
6.40)
<0.001
Denutrition 74/787 9.40 43/516 8.33 31/271 11.44 1.42 (0.87–
2.31)
0.16
Renal disease 27/831 3.25 24/558 4.30 3/273 1.10 0.25 (0.07–
0.83)
0.02
Cancer 13/831 1.56 7/553 1.27 6/278 2.16 1.72 (0.57–
5.17)
0.33




Completed 389/670 58.06 257/433 59.35 132/237 55.70 0.93 (0.62–
1.39)
0.70
Cured 140/670 20.90 90/433 20.79 50/237 21.10 Reference -
(Continued )
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give paucibacillary samples, were overrepresented among the culture-negative patients (data
not shown) [2,14].
Characteristics of TB patients
Information on native country was available for 850 of the 945 patients (Table 1): 24.4%
(n = 207) of the Brussels TB patients were born in Belgium, the remaining 75.7% (n = 643) in
76 different countries, the majority (n = 372, 43.8%) being from Africa: 22.6% from Sub-Saha-
ran Africa and 21.2% from North-Africa. The most frequently encountered native countries
were Morocco (18.7%) and the Democratic Republic of Congo (6.6%). Among the TB patients
living in Brussels, 24.9% were asylum-seekers or undocumented immigrants.
Most of the patients belonged to the active population age group with a mean age of 38.4
years (standard deviation (SD) = 18.0). No significant difference in age was observed between
patients born in Belgium (mean age = 39.2 years, SD = 23.2) and foreign-borns (meanage = 38.0
years, SD = 16.0 years). Among Belgian-born patients the females (mean age 35.0 years) were
younger than the males (mean age 41.5 years), but this difference was not significant. The
overall sex ratio was 1.8 (608 males and 337 females). In very young children (< 2 years), boys
(n = 18) were more often affected than girls (n = 7) (sex ratio: 2.6).
Information on the biological origin of the isolates was available for 920 patients. The vast
majority were isolated from the respiratory tract (75.8%) followed by lymph nodes (15.4%),
pleural fluid (3.4%) and other sites (see Table 1). A pulmonary infection site was significantly
less frequent among foreign patients (72.8%) than among Belgian ones (82.0%) (p = 0.004)
while lymphatic infection was significantly more frequent among the former (18.0% versus
9.8%, p = 0.006).
At the time of sampling, 66.0% of the patients were hospitalized and 51.0% of pulmonary
cases were smear microscopy positive (see Table 1). For 6.5% of the patients (n = 51), a previ-
ous history of TB was registered. These relapses occurred on average 9.2 years (SD = 9.3) after
the first TB occurrence (data available for 43 of the 51 patients).
Analysis of risk factors revealed that 6.0%, 3.1%, 41.4% of the patients were registered as
alcohol abuser, prisoner and/or underprivileged, respectively. Moreover, HIV-positive patients
accounted for 8.0% of the study population and 9.4% were notified as suffering from malnutri-
tion. For 23.3% of the patients a recent contact with a TB patient was recorded.
At the end of the study period, treatment outcome at 12 months was available for 716
patients; 46 were still on treatment. Out of the 670 patients remaining, 529 (79.0%) had com-
pleted their treatment successfully. There are no significant differences between the clustered
and non-clustered TB cases regarding these parameters.
Table 1. (Continued)
Category All strains included in the
study (n = 945)
Non-clustered strains
(n = 624)

















Defaulted 116/670 17.31 72/433 16.63 44/237 18.67 1.10 (0.66–
1.83)
0.71
Died tuberculosis 11/670 1.64 7/433 1.62 4/237 1.69 1.03 (0.29–
3.69)
0.97
Died other morbidity 7/670 1.04 4/433 0.92 3/237 1.27 1.35 (0.29–
6.27)
0.70
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Molecular typing and clustering analysis
The 945 TB isolates included in this study were submitted to genotyping by standardized MIR-
U-VNTR typing and spoligotyping. Genotypes were interpretable for 910 strains (S1 File). The
majority (n = 880) of the TB cases were infected by M. tuberculosis but 16 were infected by M.
africanum and 14 by M. bovis. The distribution of the M. tuberculosis genetic families is pre-
sented in Table 1. The large majority of the strains belonged to the Euro-American lineage,
with sublineages Latin-American-Mediterranean (LAM) (16.7%) and Haarlem (15.7%) being
the most prevalent.
Of the 910 isolates, only 6 reproducibly displayed a double allele in a single MIRU-VNTR
locus each (MIRU 27, VNTR 1955, VNTR 0424, VNTR 4052, VNTR 2163b, MIRU 10). For
these isolates, the double allele was considered for possible overlaps of clusters identification.
Two of them were involved in one cluster each and included in this study. The combined use
of spoligotyping and MIRU-VNTR for the cluster analysis had no effect on the resolution
power obtained by using MIRU-VNTR typing alone.
Cluster analysis, applied to the 910 genotypable isolates, allowed the identification of 113
clusters involving 321 (35.3%) of the TB patients. These results yield a strain-clustering rate of
22.9%. Cluster size ranged from 2 to 11 patients with the following distribution: cluster of 2
patients (n = 68), 3 (n = 25), 4 (n = 7), 5 (n = 6), 6 (n = 4), 7 (n = 1), 10 (n = 1) and 11 (n = 1).
Similar to the global population, the sublineages LAM (21.5%) and Haarlem (18.1%) were the
most prevalent among the clustered strains. Of the 589 patients whose strain did not belong to
any cluster, 80.8% were foreign-born.
No significant difference in the percentage of smear positive samples was observed between
patients involved in a cluster and patients infected by an isolate presenting a unique pattern.
However, more pulmonary infections (82.3% versus 72.1%, p<0.01) and Belgian-born persons
(33.9% versus 19.2%, p<0.01) were observed among patients involved in clusters. Moreover,
more males (p = 0.008) and children (less than 15 years, p<0.001) were observed in this clus-
tered population. Among the children, the majority (17/24) were under 3 years of age and had
clear familial or contact links with the other members of their cluster. Being an alcohol abuser
(p = 0.008) or having had a recent contact with a TB patient (p<0.001) were also a strain-clus-
tering predictor.
Although 100 of the 321 patients involved in clusters were Belgian-born, epidemiological
investigations could establish a foreign connection (e.g. foreign parents or wife/husband, fre-
quent journeys abroad) for 33 among them. Globally, 10 clusters comprised exclusively Bel-
gian-born patients (n = 27), 57 consisted of only foreign-born patients (n = 134) and 46
presented a mix of both (n = 160). In most of the mixed clusters (n = 41), the foreign-born
patients were long-time residents in Belgium. Only 5 clusters presented a mix of Belgian-born
patients and recently arrived asylum-seekers or unsettled (often undocumented) immigrants.
Analysis of information collected by the field staff of the two Belgian TB associations,
VRGT and FARES, during molecular-guided epidemiological investigations, supplemented by
data obtained during routine surveillance activities, revealed family transmission or social con-
tact for 58 and 21 patients respectively, distributed over 34 clusters. Patients with undetermined
links but living in geographic proximity and patients presenting only links of geographical ori-
gin were included in 23 (63 patients) and 64 (107 patients) clusters respectively. Distribution of
the strain-clusters according to the epidemiologic links identified between the involved patients
is presented in Fig 1. No obvious link was detected for 72 patients.
Isolates presenting the spoligotype 776000000000171, identified in 2003–2005 as responsi-
ble for a large outbreak (41 patients) in Brussels [11] were again detected in this study. Eigh-
teen patients were infected, of whom 15 were included in 4 clusters. Among these 15 strain-
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clustered patients, 9 were Belgian-born and 9 had confirmed familial (n = 7) or social (n = 2)
links.
One of the 4 clusters contained strains presenting also the same MIRU-VNTR profile as
those analysed during the Brussels outbreak. Two clusters differed by variations in a single
locus (VNTR 4052) and the fourth one presented a divergent MIRU-VNTR profile with varia-
tions in 5 loci (MIRU 40, VNTR 2163b, MIRU 16, VNTR 4052 and VNTR 2165). Concerning
the three patients sharing this spoligotype but not involved in clusters, variations in the MIR-
U-VNTR profiles were observed, respectively, in a single locus (n = 1), four loci (n = 1) and 18
loci (n = 1).
Drug susceptibility
Drug susceptibility results were available for 922 of the 945 isolates included in the study. The
vast majority (91.4%) were susceptible to isoniazid and rifampicin, the two main antibiotics
used for TB treatment. However, 30 strains (3.3%) showed resistance to these two drugs and
Fig 1. Repartition of the clusters according to the links identified between the patients. Clusters are represented by unique identification numbers.
Next to the cluster number, the number of patients for who an epidemiological link was detected is indicated (i.e. 2/3: two of the three patients included in the
cluster present this link). f: familial link; o: same geographic origin; p: geographic proximity. Clusters in orange contain more than 3 patients and cluster in
grey more than 6. The purple boxes indicate the number of clusters belonging to each category (or combination of categories) of links. The blue boxes
indicate clusters comprising exclusively Belgian-born patients. The green boxes indicate clusters with strains presenting the 776000000000171 spoligotype
(S-family).
doi:10.1371/journal.pone.0172554.g001
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were, therefore, identified as multi-drug resistant (MDR) strains. Among these, 4 were consid-
ered extensively drug resistant (XDR) presenting additional resistance to any fluoroquinolone
and to at least one injectable second-line drug. Comparing the MDR subgroup of patients to
those infected by a susceptible TB strain, the former present a significantly higher frequency of
previous history of TB (65.4% against 5.6%; p<0.001). Pulmonary infections were also more fre-
quent in the MDR subgroup of patients compared to those infected by a susceptible TB strain
(89.7% against 75.3%) but this difference was not significant (p = 0.09). Out of the 30 MDR TB
patients, 13 had not yet completed their treatment at the end of the study period. Among the 17
who did, 15 were cured, a cure rate of 88.2%. One patient died, and 1 was lost to follow-up.
The analysis of the genetic lineage among the MDR subgroup showed a strong presence of
strains belonging to the Beijing family (39.9% versus 2.9% in the non-MDR patients;
p = 0.049) while strains of the Haarlem family are less frequent in this subgroup (3.3% versus
16.2%; p = 0.57). Analysis of the native countries showed that MDR patients are mainly for-
eign-born (92.6%) with many (40.7%) originating from Eastern Europe, against only 9.8%
among the non-MDR patients (p = 0.001). These two observations are linked as MDR patients
infected by a Beijing strain (n = 12) are nearly all (10/12) natives from Eastern European coun-
tries: Georgia (n = 5), Latvia (n = 1), Poland (n = 1) and Russia (n = 3).
Discussion
This report presents the conclusion of a population-based molecular epidemiology study con-
ducted over the period 2010–2013 on 945 positive cultures TB patients living in Brussels-Capi-
tal Region. The proportion of the TB patients in Brussels that is foreign-born (75.7%) has
hardly changed when compared to a similar epidemiological study in Brussels realized eight
years earlier (2002–2005) which found a proportion of foreign-born TB patients of 78.8% [11].
The two studies also show an evolution of the difference in patients’ age distribution
between Belgian-born and foreign-born patients. The previous study revealed a substantial dif-
ference in the mean age of Belgian-born (51 years) and foreign-born (32 years) patients while
this difference seems to have been erased in the present study, with mean ages of 39.3 and 38.4
years, respectively [21]. This observation could be linked to the progressive disappearance of
Belgian-born people infected at a young age who developed an active tuberculosis later (birth-
cohort effect). Public Health campaigns promoting hygiene, the increase of the standard of liv-
ing, social protection mechanisms, improved working conditions [22] and the introduction of
antibiotics in the treatment during the post-war period are key elements explaining this reduc-
tion of infection. At the national level, a similar decrease of TB among persons over 65 years of
age was reported and seems to be related to a cohort effect mainly observed in the Belgian pop-
ulation [2].
The study identified classic risk factors for TB transmission such as being underprivileged
(41.4%), having a recent contact with a TB patient (23.2%) or being asylum-seekers or undocu-
mented immigrants (24.9%). Having a previous history of TB was also confirmed to be a MDR
TB predictor. It should be noted that the definition of some of the risk factors is not precise
and the data should therefore be interpreted with caution.
The treatment success rate obtained in the study population in the Brussels-Capital Region
(79.0%) is comparable to the result obtained in the rest of the country (77.3% average of the
cohorts 2010–2013 in the Flemish and Walloon regions) (reference national TB registers
2011–2014).
The cure rate of 88.2% among 17 MDR TB patients in the study in Brussels-Capital Region
is comparable to the 83.7% obtained in the MDR cohorts 2010–2013 in the other regions of
the country (Flanders and Wallonia) [23].
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The phylogenetic analysis of the isolates showed that the LAM (16.7%) and Haarlem
(15.7%) branches are the two most prevalent TB lineages circulating in Brussels. However,
analysis of the MDR subgroup showed an association with Beijing strains (39.9%) and patients
native of East-Europe (40.7%), as also reported globally in Belgium [23,24] and in the Euro-
pean Union [25,26]. These observations were also mentioned during the previous epidemio-
logical study conducted in Brussels, indicating a stable phylogenetic distribution of the strains.
In 2003–2005, an outbreak including 41 patients infected by a strain belonging to the S genetic
family and presenting the spoligotype 776000000000171 (octal code) was described [11]. In
the present study, 18 additional strains presenting this pattern were identified, showing that
the strain S-Brussels is still actively transmitted in the community about 8 years after its first
detection and that MIRU-VNTR variants are emerging.
Genotyping of the TB strains allowed the detection of 113 clusters involving 321 patients,
giving a recent transmission index of 22.9% compared to 19.8% reported previously (2002–
2005) [14]. These data illustrate the stability of the TB context in the Brussels-Capital Region
but also prove the necessity of remaining vigilant and maintaining the TB control efforts. As
most of the TB patients in Brussels-Capital Region are foreign-born, it is likely that many
among them were infected in their native country. Arguments in favour of this assumption are
that proportion-wise, significantly more Belgian-born than foreign-born patients belonged to
a cluster while, inversely, the latter were infected more often by an isolate with a unique genetic
profile. The fact that genotyping revealed that the strain of 64.7% of the patients (n = 589) pre-
sented a unique genotype demonstrates the large genetic diversity of the TB strains isolated
from patients living in Brussels.
Among the 113 clusters that were detected, 57 (50.4%) consisted of foreign-born patients
only while 46 (40.7%) constituted a mix of Belgian-born and foreign-born patients. In the ear-
lier study, these percentages were 58.5% and 32.1% respectively, suggesting a shift from for-
eign-born only to mixed clusters. However, in both studies, the foreign-borns in most of the
mixed clusters were settled immigrants who were long-time residents in the country. Only 3
out of 17 mixed clusters in the previous study and 5 out of 46 in the present study presented a
mix of Belgian-born patients and recently arrived asylum-seekers or unsettled immigrants,
revealing limited cross-national TB transmission [27].
Additional investigations of the 113 clusters detected during the present study showed evi-
dent links, such as familial/social contact, same geographic origin or geographic proximity of
the places of residence, within 87 clusters. By using only conventional epidemiological surveil-
lance (based on routinely collected information such as recent contact with a TB patient or
familial/social links) and not genotyping, a clear link would only have been established for
19.3% of the strain-clustered patients. This analysis confirms that molecular epidemiology of
M. tuberculosis has become an important determinant for TB control programs. Moreover,
with many laboratories currently implementing new technologies such as whole genome
sequencing, a better discriminatory power among clusters will soon be possible [26].
In addition to detecting laboratory cross contamination and clerical errors, molecular sur-
veillance has led to the identification of unsuspected transmission chains and, accordingly, the
subsequent development of targeted interventions [28]. In this way, the detection of patient
clusters is helping the Public Health Organisations to respond to TB outbreaks more effectively
and improve TB management and control in the country.
To enjoy the benefit of molecular surveillance in practice, a close collaboration between lab-
oratories and public healthcare workers is needed to quickly perform genotyping after TB cul-
ture positivity and implement control measures as soon as the result is available. However,
during the present study it came to the fore that the main obstacle to a TB control strategy
based on molecular surveillance in Belgium are the budgetary restrictions that do not allow to
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carry out extensive field investigations and contact tracing for each of the clusters identified.
Another consequence of the current limited financial means is the impossibility to genotype
all the TB strains isolated in Belgium although a country-wide monitoring has been proven to
be more efficient [28].
Given the high cost required to treat a TB patient, as evidenced by different studies [23,29],
a financial investment in molecular surveillance and the epidemiological investigations it
entails would be economically favourable.
Conclusion
The TB epidemiological situation in the Brussels-Capital Region (Belgium) has remained sta-
ble between the periods 2002–2005 and 2010–2013, with the exception of the mean age differ-
ence between Belgian-born and foreign-born patients which probably has disappeared as a
result of a cohort effect.
Cluster analysis has revealed that only limited trans-national transmission is taking place,
but it is clear that one country on its own will not be able to eliminate TB within its territory. A
global approach to TB control is required.
Molecular surveillance has a clear added value as it allows to identify clustering, laboratory
contamination, clerical errors and unsuspected transmission chains. But sufficient financial
means need to be available to perform all required epidemiological investigations to establish
linkages and to genotype all the TB strains isolated in the country.
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